Andrzej Wróbel Selected Research

Imipramine (Janimine)

10/2017	SN003, a CRF1 receptor antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13-cis-retinoic acid in rats.
11/2007	Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression.
11/2004	Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
11/2004	Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
11/2002	Effect of joint administration of imipramine and amantadine on binding of [3H]7-OH-DPAT to dopamine D3 receptors in peripheral blood lymphocytes of the patients with drug-resistant unipolar depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej Wróbel Research Topics

Disease

21	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 05/2008
6	Inflammation (Inflammations) 01/2022 - 07/2015
5	Mood Disorders (Mood Disorder) 01/2020 - 09/2005
5	Depressive Disorder (Melancholia) 11/2018 - 11/2002
4	Neoplasms (Cancer) 02/2022 - 01/2021
4	Stress Urinary Incontinence 09/2021 - 09/2003
4	Cystitis 05/2021 - 06/2017
4	Mental Disorders (Mental Disorder) 02/2016 - 10/2014
3	Endometrial Neoplasms (Endometrial Cancer) 02/2022 - 11/2002
3	Edema (Dropsy) 05/2021 - 06/2017
3	Hemorrhagic Cystitis 05/2021 - 06/2017
3	Urge Urinary Incontinence (Urge Incontinence) 10/2017 - 01/2010
2	Seizures (Absence Seizure) 04/2020 - 01/2020
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2004 - 01/2004
1	Dehydration (Water Stress) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Margins of Excision 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 03/2021
1	Obesity 01/2021
1	Abdominal Obesity 01/2021
1	Cognitive Dysfunction 01/2021
1	Pelvic Organ Prolapse 12/2020
1	Urinary Tract Infections (Urinary Tract Infection) 10/2020
1	Necrosis 09/2020
1	Urinary Bladder Diseases (Bladder Diseases) 03/2020
1	Hemorrhage 01/2019

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 05/2021 - 11/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021 - 07/2015
5	Imipramine (Janimine)FDA LinkGeneric 10/2017 - 11/2002
4	Antidepressive Agents (Antidepressants)IBA 01/2019 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2020 - 01/2020
3	O-1602 compoundIBA 09/2020 - 03/2020
3	blebbistatinIBA 01/2019 - 01/2019
3	rho-Associated KinasesIBA 10/2018 - 05/2008
3	Amantadine (Aman)FDA LinkGeneric 11/2007 - 11/2002
2	Cholinergic Antagonists (Anticholinergics)IBA 09/2021 - 01/2010
2	asiatic acidIBA 05/2021 - 01/2020
2	Polypropylenes (Polypropylene)IBA 12/2020 - 09/2003
2	Nerve Growth Factor (NGF)IBA 09/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2020 - 01/2019
2	OccludinIBA 09/2020 - 01/2019
2	Pentylenetetrazole (Metrazol)IBA 04/2020 - 01/2020
2	Vigabatrin FDA Link 04/2020 - 01/2020
2	gamma-Aminobutyric Acid (GABA)IBA 04/2020 - 01/2020
2	CannabinoidsIBA 01/2020 - 11/2018
2	retinol acetateIBA 01/2019 - 07/2015
2	Muscarinic AntagonistsIBA 01/2017 - 07/2016
2	Caffeine (No Doz)FDA LinkGeneric 02/2016 - 09/2015
2	GlucocorticoidsIBA 12/2015 - 10/2014
1	SeleniumIBA 02/2022
1	CreatinineIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2021
1	Hypnotics and Sedatives (Sedatives)IBA 09/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Nucleic AcidsIBA 03/2021
1	LipidsIBA 03/2021
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2021
1	Plant ExtractsIBA 12/2020
1	canephron NIBA 10/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Calcitonin Gene-Related PeptideIBA 09/2020
1	Malondialdehyde (Propanedial)IBA 09/2020
1	3-nitrotyrosineIBA 09/2020
1	InterleukinsIBA 09/2020
1	CationsIBA 09/2020
1	Ethosuximide (Zarontin)FDA LinkGeneric 04/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 04/2020
1	Clonazepam (Rivotril)FDA LinkGeneric 04/2020
1	4-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)IBA 04/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 04/2020
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	CorticosteroneIBA 01/2020
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	HemopexinIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	UromodulinIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Orosomucoid (Seromucoid)IBA 01/2019
1	Myosin Type IIIBA 01/2019
1	SolutionsIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019

Therapy/Procedure

7	Therapeutics 01/2021 - 11/2002
6	Drug Therapy (Chemotherapy) 03/2020 - 10/2014
3	Suburethral Slings (Tension-Free Vaginal Tape) 10/2020 - 04/2007
1	Urinary Diversion (Ileal Conduit) 01/2022
1	Nephrectomy 01/2022
1	Fluid Therapy (Oral Rehydration Therapy) 01/2022
1	Laparotomy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Hysterectomy 12/2020
1	Operative Surgical Procedures 01/2019